Qilu hosipital
Jinan, Shandong, 257000, China
NCT Number: NCT04850209
In this study, effects of oral and written education, WeChat education plus oral and written education on Helicobacter pylori eradication will be compared in a randomized way.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Jinan, Shandong, 257000, China
There are two randomized parallel groups in this study, control group and Wechat group.All of the patients will be treated with Amoxicillin + Clarithromycin + Bismuth + Vonoprazan fumarate. In control group,the patients will be educated by oral and written way about the regimen. In Wechat group, the patients will be educated by Wechat oral and written way. Then, the eradication rates, compliance, adverse events, patients' satisfaction and experience will be evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral and written education
Wechat group: oral and written education plus Wechat group based interactive education provided by medical professional
Time frame: 2 months
Six weeks after completion of treatment,number of patients get H.pylori eradicated supported by negative 13C-UBT results will be investigated by an independent researcher.Then eradication rate in each group will be calculated by using intention-to-treat analysis and per-protocol analysis.
Time frame: 14 days
At the follow-up,adverse events complained by patients will be recorded by an independent researcher,meanwhile a 8 point visual analog scale (VAS) was used to evaluate severity of adverse events.
Time frame: 14 days
compliance was evaluated by assessing the total pills patients have taken.Compliance was defined as good when more than 80% or less than 120% of the total pills were taken.
Shandong University
Other
The Impact of Interactive Patient Education Based on WeChat Group on the Eradication Rate of Helicobacter Pylori
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06561711
Helicobacter Pylori Infection, cyclopia sequence
Beijing, Beijing Municipality, China
View Trial DetailsNCT07122284
Gut Microbiota, Helicobacter Pylori Infection
Xiamen, Fujian, China
View Trial DetailsNCT06340334
Furazolidone, Helicobacter Pylori Infection
Nanjing, China
View Trial DetailsNCT06412588
Helicobacter Pylori Infection
Nanjing, Jiangsu, China
View Trial Details